Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 2,247,094 |
|
|||||
| News | - | ||||||
| Day High | 108.19 | Low High |
|||||
| Day Low | 105.25 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.33 | 1.25% | 107.51 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 106.18 | 105.25 | 108.19 | 107.97 | 106.18 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 36,296 | 2,247,094 | US$ 107.44 | US$ 241,434,476 | - | 62.55 - 142.79 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:50 | formt | 105 | US$ 107.51 | USD |
Moderna (MRNA) Options Flow Summary
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 41.25B | 382.07M | - | 6.85B | -4.71B | -12.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moderna News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 102.37 | 111.29 | 99.30 | 105.84 | 2,880,696 | 5.14 | 5.02% |
| 1 Month | 106.40 | 115.89 | 97.00 | 105.65 | 3,054,556 | 1.11 | 1.04% |
| 3 Months | 97.39 | 115.89 | 84.06 | 100.65 | 3,819,698 | 10.12 | 10.39% |
| 6 Months | 76.73 | 115.97 | 62.55 | 93.71 | 4,427,572 | 30.78 | 40.11% |
| 1 Year | 134.67 | 142.79 | 62.55 | 102.53 | 4,043,597 | -27.16 | -20.17% |
| 3 Years | 171.79 | 497.17 | 62.55 | 219.63 | 6,998,869 | -64.28 | -37.42% |
| 5 Years | 25.83 | 497.17 | 11.54 | 147.51 | 8,829,842 | 81.68 | 316.22% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
